IH, Brain Health, and T2D

Recruiting now · Not applicable · Has a placebo group

Conditions studied: Type 2 Diabetes, Aging

In brief

The purpose of this study is to use a randomized, placebo-controlled study design to rigorously examine the therapeutic potential of intermittent hypoxia (IH) for improving cerebrovascular health in older adults with and without type 2 diabetes mellitus (T2DM).

Key facts

Study ID
NCT07173543
Run by
Darren P Casey
People needed
80
Starts
2025-09-22
Expected to finish
2028-06-30
Last updated by the study team
2026-03-13

Who can join

Age: 60 and older, up to 85. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.